BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 4624350)

  • 1. Increase of serum growth hormone concentration following thyrotropin-releasing hormone injection in patients with acromegaly or gigantism.
    Irie M; Tsushima T
    J Clin Endocrinol Metab; 1972 Jul; 35(1):97-100. PubMed ID: 4624350
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum growth hormone and prolactin response to thyrotropin-releasing hormone in patients with acromegaly before and after surgery.
    Samaan NA; Leavens ME; Jesse RH
    J Clin Endocrinol Metab; 1974 Jun; 38(6):957-63. PubMed ID: 4208807
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma growth hormone response to thyrotropin-releasing hormone in patients with active acromegaly.
    Faglia G; Beck-Peccoz P; Ferrari C; Travaglini P; Ambrosi B; Spada A
    J Clin Endocrinol Metab; 1973 Jun; 36(6):1259-62. PubMed ID: 4196265
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum levels of thyrotropin, prolactin, growth hormone, triiodothyronine and thyroxine after oral administration of thyrotropin releasing hormone in hypothyroid and hyperthyroid patients.
    Nedvídková J; Felt V
    Endokrinologie; 1976; 68(2):175-82. PubMed ID: 827434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inappropriate secretion of thyrotropin: discordance between the suppressive effects of corticosteroids and thyroid hormone.
    Smallridge RC; Wartofsky L; Dimond RC
    J Clin Endocrinol Metab; 1979 Apr; 48(4):700-5. PubMed ID: 107182
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypothalamic hypothyroidism: diminished thyroidal response to thyrotropin-releasing hormone.
    Mitsuma T; Shenkman L; Suphavai A; Hollander CS
    Am J Med Sci; 1973 Apr; 265(4):315-9. PubMed ID: 4196283
    [No Abstract]   [Full Text] [Related]  

  • 7. Growth hormone and changes in the secretion of thyrotropic hormone after thyrotropin-releasing hormone (TRH): ineffectiveness of dopaminergic stimulation.
    Felt V; Nedvídková J
    Endokrinologie; 1982 Oct; 80(2):201-6. PubMed ID: 6819130
    [No Abstract]   [Full Text] [Related]  

  • 8. [Growth hormone secretion in relation to changes in thyrotropic hormone after thyroliberin in patients with acromegaly and dopaminergic stimulation (author's transl)].
    Felt V; Nedvídková J
    Cas Lek Cesk; 1982 Apr; 121(16):489-93. PubMed ID: 6807547
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral thyrotropin-releasing hormone (TRH) test in acromegaly.
    Marek J; Límanová Z; Srámková J
    Endokrinologie; 1981 Oct; 78(1):57-66. PubMed ID: 6797816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyrotropin releasing hormone (TRH) studies in patients with thyroid cancer.
    Samaan NA; Beceiro JR; Hill CS; Haynie TP; Glenn HJ
    J Clin Endocrinol Metab; 1972 Sep; 35(3):438-43. PubMed ID: 4626272
    [No Abstract]   [Full Text] [Related]  

  • 11. Transient lack of thyrotropin (TSH) response to thyrotropin-releasing hormone (TRH) in treated hyperthyroid patients with normal or low serum thyroxine (T4) and triiodothyronine (T3).
    Sanchez-Franco F; García MD; Cacicedo L; Martin-Zurro A; Escobar del Ray F; Morreale de Escobar G
    J Clin Endocrinol Metab; 1974 Jun; 38(6):1098-102. PubMed ID: 4208806
    [No Abstract]   [Full Text] [Related]  

  • 12. Pituitary-thyroid responsiveness to intramuscular thyrotropin-releasing hormone based on analyses of serum thyroxine, tri-iodothyronine and thyrotropin concentrations.
    Azizi F; Vagenakis AG; Portnay GI; Rapoport B; Ingbar SH; Braverman LE
    N Engl J Med; 1975 Feb; 292(6):273-7. PubMed ID: 803298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parameters of thyroid function in patients with active acromegaly.
    Corrigan DF; Wartofsky L; Dimond RC; Schaaf M; Earll JM; Rogers JE; Wright FD; Burman KD
    Metabolism; 1978 Feb; 27(2):209-16. PubMed ID: 414050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of somatostatin to suppress thyrotropin releasing factor and luteinizing hormone releasing factor-induced growth hormone release in acromegaly.
    Giustina G; Reschini E; Peracchi M; Cantalamessa L; Cavagnini F; Pinto M; Bulgheroni P
    J Clin Endocrinol Metab; 1974 May; 38(5):906-9. PubMed ID: 4207370
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of thyrotropin releasing hormone-mediated secretion of thyrotropin by human growth hormone.
    Root AW; Snyder PJ; Rezvani I; DiGeorge AM; Utiger RD
    J Clin Endocrinol Metab; 1973 Jan; 36(1):103-7. PubMed ID: 4629131
    [No Abstract]   [Full Text] [Related]  

  • 16. Elevations in plasma growth hormone concentration after luteinizing hormone-releasing hormone (LRH) in patients with active acromegaly.
    Faglia G; Beck-Peccoz P; Travaglini P; Paracchi A; Spada A; Lewin A
    J Clin Endocrinol Metab; 1973 Aug; 37(2):338-40. PubMed ID: 4198260
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthetic thyrotropin-releasing hormone. A potent stimulator of thyrotropin secretion in man.
    Anderson MS; Bowers CY; Kastin AJ; Schalch DS; Schally AV; Snyder PJ; Utiger RD; Wilber JF; Wise AJ
    N Engl J Med; 1971 Dec; 285(23):1279-83. PubMed ID: 5000322
    [No Abstract]   [Full Text] [Related]  

  • 18. Growth hormone assay in acromegaly, gigantism, dwarfism and hypopituitarism.
    Daughaday WH
    Postgrad Med; 1969 Nov; 46(5):84-91. PubMed ID: 5361738
    [No Abstract]   [Full Text] [Related]  

  • 19. [Peripheral thyroid function and TRH-TSH test in patients with acromegaly].
    Heberling HJ; Heilmann W; Ulrich FE; Schneyer U
    Z Gesamte Inn Med; 1981 Apr; 36(8):306-8. PubMed ID: 6792802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Further findings on the action of synthetic thyrotropin releasing hormone on the TSH serum level in various endocrine diseases].
    Wagner H; Böckel K; Grote G; Hrubesch M; Vosberg H; Junge-Hülsing G; Hauss WH
    Med Welt; 1972 Oct; 23(41):1419-21. PubMed ID: 4628828
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.